Publications
22
Citations
617
Est. group size
~26
Recurring co-author estimate
Active years
7
Publishing since 2020
Typically publishes in teams of ~9 · 0% small-team papers (≤3 authors) · across 6 venues
- MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapy
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Genetically Engineered and Implantable Mouse Brain Tumor Models: Characterization by Immunohistochemistry and Flow Cytometry
Current Protocols · 2025
- Peripheral blood mononuclear cell (PBMC)- based functional evaluation of human T cell response to suppressive cells and immune-oncology therapeutics
Methods in cell biology · 2025
- CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Miniaturized microarray-format digital ELISA enabled by lithographic protein patterning
Biosensors and Bioelectronics · 2023
- Murine brain tumor microenvironment immunophenotyping using mass cytometry
STAR Protocols · 2022
- Extrafollicular CD4 T cell-derived IL-10 functions rapidly and transiently to support anti-Plasmodium humoral immunity
PLoS Pathogens · 2021
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Neuro-Oncology×2
- ACS Nano×1
- Frontiers in Molecular Neuroscience×1
- Science Advances×1
- Mahmoud S. Alghamri
Medicine · University of Michigan
- Ayman Taher
Medicine · University of Michigan
- Siva Kumar Natarajan
Medicine · University of Michigan
- Jorge A. Peña Agudelo
Medicine · University of Michigan
- David Altshuler
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile